Table 4.

Subgroup analyses based on eGFR categories in subjects not on dialysis

Variables	No. of Patients	No. of Events	Event Rates*	Hazard Ratio (95% CI)	P-value	Test of Interaction
Outcome: Death						0.15
eGFR <45
EES	395	61	21.74	0.71[0.49,1.03]	0.07
CABG	395	83	25.95	Reference
eGFR 45-60
EES	1073	99	14.4	1.01[0.74,1.38]	0.94
CABG	1073	109	13.0	Reference
Outcomes: Myocardial Infarction						0.96
GFR <45
EES	395	26	8.64	1.75[0.86,3.56]	0.12
CABG	395	14	4.73	Reference
GFR 45-60
EES	1073	60	7.56	1.79[1.12,2.84]	0.01
CABG	1073	37	4.5	Reference
Outcome: Stroke						0.20
GFR <45
EES	395	14	4.95	0.71[0.34,1.48]	0.36
CABG	395	20	6.31	Reference
GFR 45-60
EES	1073	18	2.4	0.37[0.20,0.70]	0.002
CABG	1073	43	4.9	Reference
Outcome: Repeat Revascularization						0.58
GFR <45
EES	395	68	22.32	1.69[1.04,2.75]	0.03
CABG	395	32	11.15	Reference
GFR 45-60
EES	1073	200	24.9	1.98[1.51,2.58]	<0.0001
CABG	1073	114	14.2	Reference

^*Kaplan-Meier Estimate.

CABG = coronary artery bypass graft surgery; EES = everolimus eluting stent.